Among triple-negative breast cancers, HER2(0) breast cancer shows a strong tendency to be basal-like compared with HER2(1+) breast cancer: preliminary results

Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma

(2017) Fereshteh Mohammadizadeh et al.   Cancer Biomarkers

Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situhybridization (FISH): pathologist assessment compared to quantitative image analysis

(2009) Gulisa Turashvili et al.   BMC CANCER

Molecular Classification of Breast Carcinomas by Immunohistochemical Analysis

(2009) Ping Tang et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Pathological definition of triple negative breast cancer

(2009) Giuseppe Viale et al.   EUROPEAN JOURNAL OF CANCER

Current issues in ER and HER2 testing by IHC in breast cancer

(2008) Allen M Gown   MODERN PATHOLOGY

Loss of Bcl-2 expression in colon cancer: A prognostic factor for recurrence in stage II colon cancer

(2008) Laurent Poincloux et al.   SURGICAL ONCOLOGY-OXFORD

Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers

(2007) Hui Liu et al.   HUMAN PATHOLOGY

Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype

(2007) B Mahler-Araujo et al.   JOURNAL OF CLINICAL PATHOLOGY